Search Results - "Molina, Helen"

Phase II Multi-institutional Clinical Trial Result of Concurrent Cetuximab and Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma by Chung, Christine H, Li, Jiannong, Steuer, Conor E, Bhateja, Priyanka, Johnson, Matthew, Masannat, Jude, Poole, Maria I, Song, Feifei, Hernandez-Prera, Juan C, Molina, Helen, Wenig, Bruce M, Kumar, Sunil, Kuperwasser, Charlotte, Stephens, Philip J, Farinhas, Joaquim M, Shin, Dong M, Kish, Julie A, Muzaffar, Jameel, Kirtane, Kedar, Rocco, James W, Schell, Michael J, Saba, Nabil F, Bonomi, Marcelo

“…A phase II multi-institutional clinical trial was conducted to determine overall survival (OS) in patients with recurrent and/or metastatic (R/M) head and neck…”
Get full text

An epizootiological survey of necropsy cases (1993-1997) at University of the Philippines by Tateyama, S. (Miyazaki Univ. (Japan). Faculty of Agriculture), Molina, H.A, Uchida, K, Yamaguchi, R, Manuel, M.F

“…An epizootiological survey of necropsied cases (1993-1997) at University of the Philippines was performed. A total of 368 cases included 238 avian and 111…”
Get full text

Efficacy of concurrent cetuximab (CTX) and nivolumab (NIVO) in previously untreated recurrent and/or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC) by Chung, Christine H., Saba, Nabil F., Steuer, Conor Ernst, Li, Jiannong, Bhateja, Priyanka, Johnson, Matthew, Masannat, Jude, Poole, Maria, Hoening, Dirk, Song, Feifei, Hernandez-Prera, Juan C., Molina, Helen, Wenig, Bruce, Farinhas, Joaquim, Kish, Julie Ann, Muzaffar, Jameel, Kirtane, Kedar, Rocco, James William, Schell, Michael J., Bonomi, Marcelo Raul

“…Abstract only 6017 Background: Current standard of care for patients (pts) with previously untreated R/M HNSCC that are incurable is either pembrolizumab…”
Get full text

Concurrent Cetuximab and Nivolumab as a Second-Line or beyond Treatment of Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results of Phase I/II Study by Chung, Christine H, Bonomi, Marcelo, Steuer, Conor E, Li, Jiannong, Bhateja, Priyanka, Johnson, Matthew, Masannat, Jude, Song, Feifei, Hernandez-Prera, Juan C, Wenig, Bruce M, Molina, Helen, Farinhas, Joaquim M, McMullen, Caitlin P, Wadsworth, J Trad, Patel, Krupal B, Kish, Julie A, Muzaffar, Jameel, Kirtane, Kedar, Rocco, James W, Schell, Michael J, Saba, Nabil F

“…We hypothesized the combination of cetuximab and nivolumab would improve survival in recurrent and/or metastatic (R/M) HNSCC by providing synergy in cancer…”
Get full text